Pancrelipase
when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency
Approval Date: December 23, 2013
Schedule: I
Footnote: PDL
when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency
Approval Date: December 23, 2013
Schedule: I
Footnote: PDL